Concerns about the approval of lecanemab for Alzheimer's disease. Bakchine S, Colosimo C, Emilsson E, Jonsdottir SE, et al. BMJ 2025;389:r778.

Read + Share

Amedeo Smart

Independent Medical Education

Bakchine S, Colosimo C, Emilsson E, Jonsdottir SE, et al. Concerns about the approval of lecanemab for Alzheimer's disease. BMJ 2025;389:r778.
PMID: 40262845